Related Experiment Video
Updated: Jun 13, 2026

A Periprosthetic Joint Candida albicans Infection Model in Mouse
Published on: February 2, 2024
Fungal prosthetic valve endocarditis: Mayo Clinic experience with a clinicopathological analysis
Jennifer M Boland1, Heath H Chung, Frans J L Robberts
1Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA. boland.jennifer@mayo.edu
Abstract:
Fungal prosthetic valve endocarditis is a rare but devastating disease. To better characterise this syndrome, we retrospectively reviewed 21 cases of fungal prosthetic valve endocarditis seen at Mayo Clinic over the past 40 years. The average patient age was 65 years with a 2 : 1 male predominance. Twelve of 21 cases (57%) occurred within 1 year of prosthetic valve placement. The aortic valve was most commonly affected, and the most common aetiological agent was Candida species, followed by Histoplasma capsulatum. Although 20 of 21 patients (95%) were immunocompetent, they had other risk factors for fungal infection. Patients typically presented with systemic signs and symptoms of infection, and cardiac imaging was abnormal in 68% of cases. Pathological evaluation of valve material was of high yield, with organisms identified in 92% of cases who underwent valve replacement surgery or had an autopsy performed. Prosthetic valve fungal endocarditis was associated with a high morbidity and mortality, with 67% of patients experiencing complications and 57% of patients dying of infection-related disease. Hopefully, with the prompt institution of early medical therapy, surgical intervention and lifelong oral antifungal suppressive therapy, cure rates will continue to improve.
Insights
Fungal prosthetic valve endocarditis is a rare but serious condition. Early treatment and lifelong antifungal therapy may improve outcomes for this devastating infection.
Area of Science:
- Infectious Diseases
- Cardiology
- Mycology
Background:
- Fungal prosthetic valve endocarditis (FPVE) is a rare but severe complication following cardiac valve replacement.
- Prompt diagnosis and management are crucial due to high morbidity and mortality rates.
Purpose of the Study:
- To characterize the clinical presentation, risk factors, and outcomes of FPVE.
- To identify key diagnostic and therapeutic strategies for FPVE.
Main Methods:
- Retrospective review of 21 cases of FPVE at Mayo Clinic over 40 years.
- Analysis of patient demographics, clinical features, causative agents, and treatment outcomes.
Main Results:
- The average patient age was 65 years, with a 2:1 male predominance.
- Most cases (57%) occurred within 1 year of prosthetic valve placement, commonly affecting the aortic valve.
- Candida species and Histoplasma capsulatum were the most frequent pathogens. Despite most patients being immunocompetent, risk factors for fungal infection were present.
- Pathological evaluation yielded high diagnostic accuracy (92%).
- FPVE was associated with high complication (67%) and mortality (57%) rates.
Conclusions:
- FPVE is a devastating disease with significant mortality.
- Early medical therapy, surgical intervention, and suppresssive antifungal treatment are essential for improving cure rates.
- Further research into risk stratification and novel therapeutic approaches is warranted.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis I: Introduction
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Myocarditis II: Clinical Features and Diagnostic Tests
Mitral Valve Prolapse II: Assessment and Management
